Amoéba S.A. (EPA:ALMIB)

Market Cap	51.25M
Revenue (ttm)	601.60K
Net Income (ttm)	-6.59M
Shares Out	51.61M
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	214,839
Average Volume	583,843
Open	1.0120
Previous Close	0.9930
Day's Range	0.9800 - 1.0180
52-Week Range	0.4050 - 1.4400
Beta	0.64
RSI	42.97
Earnings Date	Jun 24, 2025

About Amoéba

Amoéba S.A. develops biological biocides for the prevention of microbiological risk for water, crop protection and health sectors. It develops applications using amoeba Willaertia magna C2c Maky. The company was incorporated in 2010 and is based in Chassieu, France.

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2010
• Employees: 20
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMIB

Financial Performance

In 2024, Amoéba's revenue was 601,600, a decrease of -9.44% compared to the previous year's 664,310. Losses were -6.59 million, -53.90% less than in 2023.